Compare IDEXX Laboratories, Inc. (IDXX) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs STMicroelectronics NV — how do they compare? IDEXX Laboratories, Inc. trades at $558.29 (market cap $44.48B), while STMicroelectronics NV trades at $64.74 (market cap $55.80B). The key difference: STMicroelectronics NV is the larger of the two by market cap, and STMicroelectronics NV pays a 0.58% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | STM | |
|---|---|---|
Market Cap | $44.48B | $55.80B |
Sector | Health | Financials |
52-Week High | $766.68 | $79.91 |
52-Week Low | $520.87 | $21.20 |
Enterprise Value | $45.38B | $54.01B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
STM trades at $61.57, down 0.79% with a bearish technical signal. The stock shows mixed fundamentals with a high P/E of 387.88 but strong analyst support (51.72% buy rating). Recent earnings have been inconsistent with two misses in the last three quarters, though Q3 2025 beat expectations. The company maintains solid cash flow generation of $555M in 2025 and is expanding AI partnerships with AWS and NVIDIA to drive future growth.
STM presents a cautious opportunity with 15% upside to the $72.33 consensus target, supported by AI expansion but tempered by declining revenue and thin 1.19% net margins. Key risks include execution on AI initiatives and semiconductor market volatility. The current price near support at $60 offers potential entry but requires monitoring of Q2 earnings due soon.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
